Unsupported browser detected
Your browser appears to be unsupported. Because of this, portions of the site may not function as intended.
Please install a current version of Chrome, Firefox, Edge, or Safari for a better experience.
Purpose
to identify species-conserved Group B Streptococcus proteins to be used as carrier proteins in the low-cost hexavalent GBS conjugate vaccine under development at Biovac
Grantee
Division
Global Health
Date
NOVEMBER 2018
Region Served
GLOBAL
Committed Amount
$1,767,573
Grant Topic
Pneumonia
Duration (Months)
49
Grantee Location
Seattle, Washington, United States
More about our work
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.